Misitano & Stracuzzi Valuation

Q: What is the Fair Price of O7E when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

O7E (€3.02) is trading above our estimate of [[fair value]] (€0.17)

Is O7E undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of O7E when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: O7E (€3.02) is trading above our estimate of fair value (€0.17)

Significantly Below Fair Value: O7E is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for O7E?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for O7E. This is calculated by dividing O7E's market cap by their current preferred multiple.
What is O7E's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	€94.76m

O7E key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.9x
Enterprise Value/EBITDA	7.9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does O7E's PE Ratio compare to its peers?

The above table shows the PE ratio for O7E vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	11.5x
NTG Nabaltec	9.8x	-4.3%	€131.1m
2HRA H&R GmbH KGaA	14.5x	34.9%	€139.2m
UZU Uzin Utz	10.3x	3.5%	€246.2m
ACT AlzChem Group	11.2x	9.6%	€521.0m
O7E Misitano & Stracuzzi	10.8x	n/a	€94.8m

Price-To-Earnings vs Peers: O7E is good value based on its Price-To-Earnings Ratio (10.8x) compared to the peer average (11.5x).

Price to Earnings Ratio vs Industry

How does O7E's PE Ratio compare vs other companies in the European Chemicals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	38.9%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	38.9%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: O7E is good value based on its Price-To-Earnings Ratio (10.8x) compared to the European Chemicals industry average (18.4x).

Price to Earnings Ratio vs Fair Ratio

What is O7E's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

O7E PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	10.8x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate O7E's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.